WMGI - ライト・メディカル・グル―プ (Wright Medical Group N.V.) ライト・メディカル・グル―プ



symbol WMGI
会社名 Wright Medical Group Inc. (ライト・メディカル・グル―プ)
分野(sector) Health Care   ヘルスケア
産業(industry) Industrial Specialties  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 ライト・メディカル・グループ(Wright Medical Group NV)(旧名:Tornier NV)はオランダの医療機器会社である。同社は、四肢関節と称する肩、肘、手首、手、足首及び足の筋骨格系傷害・障害を治療する外科医にソリューションの提供に焦点を当てる。同社は、外科医に四肢関節を取り扱う一連の関節置換、外傷、スポーツ医学と生物学的製品を提供する。特定の国際市場で、同社はまた、股関節と膝関節置換用製品を提供する。同社は、外科医顧客にソリューションを提供するように設計された90以上の四肢製品ポートフォリオを提供する。同社の製品ポートフォリオは、上肢関節・外傷、下肢関節・外傷、スポーツ医学と生物製剤、および大関節とその他などの製品カテゴリで構成される。同社は、北米、南米、ヨーロッパ、アフリカ、アジア、オーストラリアで現地販売および流通活動を行う。   ライト・メディカル・グル―プは、米国の整形外科医療機器メ―カ―。患者の苦痛を緩和する四肢・生物学的ソリュ―ションを提供。下肢用製品INBONE、上肢用製品MICRONAIL intramedullary(手首の骨折修復システム)や、軟組織の修復、骨移植代替、注射再生移植片などの生物学的製品を提供する。   Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
本社所在地 1023 Cherry Road Memphis TN 38117 USA
代表者氏名 Robert J. Palmisano ロバートJ.パルミサーノ
代表者役職名 President and Chief Executive Officer and Executive Director
電話番号 +31 20-675-4002
設立年月日 36465
市場名 NASDAQ National Market System
ipoyear 2011年
従業員数 1180人
url www.wmt.com
nasdaq_url https://www.nasdaq.com/symbol/wmgi
EBITDA EBITDA(百万ドル) 81.39200
終値(lastsale) 27.815
時価総額(marketcap) 2967640316.46
時価総額 時価総額(百万ドル) 3342.172
売上高 売上高(百万ドル) 792.04200
企業価値(EV) 企業価値(EV)(百万ドル) 4130.817
当期純利益 当期純利益(百万ドル) -126.09800
決算概要 決算概要 BRIEF: For the 26 weeks ended 01 July 2018 Wright Medical Group NV revenues increased 13% to $403.9M. Net loss before extraordinary items increased 92% to $110.5M. Revenues reflect U.S. Upper Extremities segment increase of 21% to $140.1M International Extremities_Biologics segment increase of 17% to $107.6M U.S. Lower Extremities_Biologics segment increase of 5% to $156.3M United States segment increase of 12% to $296.4M.



   Orthobiologics Market with (Covid-19) Impact Analysis: Top Industry Trends & Segments Forecast 2020-2027 | Stryker Corporation, Zimmer Biomet Holdings, Wright Medical Group, Arthrex  2020/11/11 16:39:09 OpenPR
Increase in demand for advanced treatment and surge in geriatric population across the globe are anticipated to significantly drive the growth of the orthobiologics market. Furthermore, rise in prevalence of spinal injuries, osteoarthritis, soft tissue injuries, and upsurge in awareness
   The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping  2020/11/05 12:54:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbott Laboratories (NYSE: ABT ) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Ascendis Pharma A/S (NASDAQ: ASND ) Athira Pharma Inc (NASDAQ: ATHA ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) Cardiff Oncology Inc (NASDAQ: CRDF ) Denali Therapeutics Inc (NASDAQ: DNLI ) - moved in sympathy with Biogen Inc (NASDAQ: BIIB ) Guardant Health Inc (NASDAQ: GH ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) Immunovant Inc (NASDAQ: IMVT ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kodiak Sciences Inc (NASDAQ: KOD ) Laboratory Corp.
   Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical  2020/11/04 12:30:00 GlobeNewswire
Kalamazoo, Michigan, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that all required regulatory approvals have been obtained for…
   Stryker wins approval to buy Wright Medical Group from U.S. antitrust regulator  2020/11/03 16:59:40 Reuters UK
Medical device maker Stryker Corp has won U.S. antitrust approval to buy Wright Medical Group on condition it sell certain assets, the Federal Trade Commission said on Tuesday.
   FTC Requires Medical Device Companies Stryker Corp. and Wright Medical Group N.V. to Divest Assets to Preserve Competition  2020/11/03 14:25:14 US Federal Trade Commission
The Federal Trade Commission will require medical device companies Stryker Corp.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 ライト・メディカル・グル―プ WMGI Wright Medical Group N.V.)


 twitter  (公式ツイッターやCEOツイッターなど)